Copyright
©The Author(s) 2022.
World J Clin Cases. Apr 16, 2022; 10(11): 3414-3425
Published online Apr 16, 2022. doi: 10.12998/wjcc.v10.i11.3414
Published online Apr 16, 2022. doi: 10.12998/wjcc.v10.i11.3414
Figure 2 Survival curves of all enrolled patients.
A: Survival curves of progression free survival; B: Survival curves of overall survival. PFS: Progression free survival; OS: Overall survival.
- Citation: Huo RX, Jin YY, Zhuo YX, Ji XT, Cui Y, Wu XJ, Wang YJ, Zhang L, Zhang WH, Cai YM, Zheng CC, Cui RX, Wang QY, Sun Z, Wang FW. Concurrent chemoradiotherapy using gemcitabine and nedaplatin in recurrent or locally advanced head and neck squamous cell carcinoma. World J Clin Cases 2022; 10(11): 3414-3425
- URL: https://www.wjgnet.com/2307-8960/full/v10/i11/3414.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i11.3414